Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis

Recruiting now

Conditions studied: Bacterial Sepsis

In brief

: Sepsis, now defined as life-threatening organ dysfunction due to a dysregulated host response to infection, is an important global health problem representing about a fifth of all global deaths. It can be associated, in some cases, with multiple organ failure and cytokine storm. The main objective of this study is to estimate and to compare the activation rate of the Nucleotide-binding domain Leucine Rich repeat containing Protein 3 (NLRP3) inflammasome in platelets between five groups of patients suffering from bacterial and/or viral sepsis, with different severity levels according to Sequential Organ Failure Assessment (SOFA) score to precise the platelets' implication in this cytokine storm.

Key facts

Study ID

NCT06657781

Run by

Centre Hospitalier Universitaire de la Guadeloupe

People needed

171

Starts

2022-11-30

Expected to finish

2026-11-01

Last updated by the study team

2024-10-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• For all groups: patients older than 18 years at inclusion and acceptation of participation by the patient, his relative or his legal representative (depending on the situation)
• For groups 1, 2, 3 and 5: Patient with a confirmed sepsis (microbiological confirmation)
• For group 4 : Patient non infected

You may not qualify if…

• Refusal of participation by the patient, his relative or his legal representative (depending on the situation)
• Patients subject to a safeguard measure of justice
• Patients younger than 18 years at inclusion

Where it is running

• Centre Hospitalier Universitaire de la Guadeloup — Les Abymes, Guadeloupe, Guadeloupe (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.